Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



What is Exome Sequencing?


What is Exome Sequencing?

The human genome consists of 3 billion nucleotides or “letters” of DNA. But only a small percentage -1.5 percent - of those letters are actually translated into proteins, the functional players in the body.

The “exome” consists of all the genome’s exons, which are the coding portions of genes. The term exon was derived from “EXpressed regiON,” since these are the regions that get translated, or expressed as proteins, as opposed to the intron, or “INTRagenic regiON” which is not represented in the final protein.


While we haven’t yet reduced the cost of sequencing the entire human genome down to an affordable $1000, the cost of sequencing just the portions that encode protein — the “functional” part of the genome — is low enough that scientists are starting to employ it in the search for genetic elements underlying traits and diseases.


For example, a team of researchers led in part by Sekar Kathiresan and Genetic Analysis Platform director Stacey Gabriel just published results of a study that used exome sequencing to highlight a gene that, when mutated, causes extremely low levels of lipids in the blood. The new gene not only represents an advance in the understanding of lipid metabolism, but also offers a novel target for developing therapies to lower cholesterol.
Exome sequencing offers a look into the genome that large-scale studies of common variation, such as the Genome-Wide Association Study (GWAS), cannot provide. GWAS can only identify variation in DNA that is common in the population, in at least one percent of people. But sequencing determines every letter in a DNA sequence, not just the ones known to vary, so it can reveal rare mutations that GWAS wouldn’t uncover. Exome sequencing is a good choice for scientists who are looking for rare mutations, especially when used as a complement to studies of common variation like GWAS. But as whole-genome sequencing becomes cheaper, that technique will likely be employed instead because it offers a look at all portions of the genome, not just those that include instructions for making proteins.


اضغط هنا للقراءة باللغة العربية

Prepared by: Dr. Feras Ali Al-Khalaf


Source :

Gilbert W (February 1978). "Why genes in pieces?". Nature 271 (5645): 501.






Other Comments

Add a comment

You must sign in to use this servcie

Username:
Password:


facebook comments

Forgot your password


sign up

Consultants Corner

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details